Lyme disease vaccine (GlaxoSmithKline)

莱姆病疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLyme disease vaccine (GlaxoSmithKline)
Drug Alias NameLYMErix
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulantsToll like receptor 2 agonists
TargetsToll like receptor 2
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsLyme Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/12/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsLyme Disease

Other Information

ATC CodeJ07AX
Related LinksWikipediaDrugBank